VCM
INSM icon

Vivaldi Capital Management’s Insmed INSM Stock Holding History

Vivaldi Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,238
Closed -$322K – 282
2025
Q3 		$322K Sell
2,238
-995
-31% -$122K 0.05% 212
2025
Q2 		$325K Buy
+3,233
New +$247K 0.05% 210
2024
Q3 		– Sell
-3,000
Closed -$201K – 234
2024
Q2 		$201K Buy
+3,000
New +$116K 0.06% 218

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vivaldi Capital Management's INSM Position: Q4 2025 in Review

Vivaldi Capital Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 2,238 shares — an estimated $322K sold.

Vivaldi Capital Management first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $325K in Q2 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Vivaldi Capital Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Vivaldi Capital Management sold 2,238 Insmed shares in Q4 2025, an estimated $322K.
  • Vivaldi Capital Management first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
  • Vivaldi Capital Management's Insmed position peaked at $325K in Q2 2025.
  • 678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Vivaldi Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.